Irinotecan Hydrochloride 67184-0513-01

Package NDC

67184-0513-01

Manufacturer: Qilu Pharmaceutical Co., Ltd.
Dosage Form: Injection, Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: May 3, 2016
Listing Expires: December 31, 2026
Application: ANDA203380

Need to source Irinotecan Hydrochloride? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Irinotecan Hydrochloride	20 mg/mL

Drug Class

Topoisomerase Inhibitor [EPC]Topoisomerase Inhibitors [MoA]

Selected Package

67184-0513-01Selected

1 VIAL, SINGLE-USE in 1 CARTON (67184-0513-1) / 15 mL in 1 VIAL, SINGLE-USE